Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 25, 2019

Creo Medical receives orders for Speedboat device

Creo Medical Group has received its first commercial orders for its Speedboat device from two hospitals in the US.

Creo Medical Group has received its first commercial orders for its Speedboat device from two hospitals in the US.

According to the company, Speedboat is the first in a range of gastrointestinal (GI) devices to be cleared for use with the Croma Advanced Energy platform.

The platform combines bipolar radiofrequency energy for precise tissue dissection along with microwave energy for coagulation and tissue ablation.

Creo Medical Group CEO Craig Gulliford said: “Initial revenues from the first device this year is once again in-line with expectations and combined with the clearance and launch of a suite of further GI devices in the coming year, we are on-track for scaling up the commercial launch of a suite of game changing GI products.

“We are all really focused on extending this impact with more physicians trained and with more products launched over the coming months.”

The purchase orders follow the successful launch of Creo Medical’s Clinical Education Programme in the US.

Content from our partners
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

They are a follow-on order of the disposable Speedboat devices following the initial sales of products for training purposes.

Creo Medical noted that these first commercial sales represent a key milestone for the company as it launches the full range of products for the CROMA platform.

GI Endoscopists in the UK, South Africa, Mainland Europe and the US have used the company’s Speedboat device to perform multiple successful treatments, removing lesions in upper as well as lower GI cases. It is designed to reduce the risks associated with alternative open, laparoscopic and existing endoscopic procedures as well as reduce extended hospital stays.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy